Regulated degradation of the inner nuclear membrane protein SUN2 maintains nuclear envelope architecture and function.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36318477.
- Also identified by DOI 10.7554/eLife.81573 and PMC identifier 9662817.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Nuclear architecture and functions depend on dynamic interactions between nuclear components (such as chromatin) and inner nuclear membrane (INM) proteins. Mutations in INM proteins interfering with these interactions result in disease. However, mechanisms controlling the levels and turnover of INM proteins remain unknown. Here, we describe a mechanism of regulated degradation of the INM SUN domain-containing protein 2 (SUN2). We show that Casein Kinase 2 and the C-terminal domain Nuclear Envelope Phosphatase 1 (CTDNEP1) have opposing effects on SUN2 levels by regulating SUN2 binding to the ubiquitin ligase Skp/Cullin1/F-Box<sup>βTrCP</sup> (SCF<sup>βTrCP</sup>). Upon binding to phosphorylated SUN2, SCF<sup>βTrCP</sup> promotes its ubiquitination. Ubiquitinated SUN2 is membrane extracted by the AAA ATPase p97 and delivered to the proteasome for degradation. Importantly, accumulation of non-degradable SUN2 results in aberrant nuclear architecture, vulnerability to DNA damage and increased lagging chromosomes in mitosis. These findings uncover a central role of proteolysis in INM protein homeostasis.
Medical subject headings
- Nuclear Envelope
- beta-Transducin Repeat-Containing Proteins